Oculis Operations S.a.r.l.
- Address
- Building D, Epfl Innovation Park
Sponsor Overview
Specializations
Retinal Disease
Oculis Operations S.a.r.l. focuses its clinical research on diabetic macular edema, a sight-threatening retinal condition associated with diabetes and central vision loss.
- Diabetic macular edema
- Retinal oedema
- Macular pathology
The sponsor’s current clinical activity is concentrated in ophthalmology across multiple countries and research sites, with an emphasis on treatment options for retinal fluid accumulation and vision impairment.
Ophthalmic Therapeutics
Its funded studies examine eye drop-based therapy for retinal disease, reflecting interest in non-invasive ophthalmic treatment approaches for patients with macular involvement.
- Topical ocular therapy
- Vision preservation
- Anterior and posterior segment drug delivery
This therapeutic area places the sponsor within clinical development efforts aimed at expanding treatment options in eye care.
Visual Function
The sponsor’s research activity is centered on outcomes relevant to visual acuity, retinal health, and the management of symptoms that affect daily functioning in people with diabetic eye disease.
- Visual acuity
- Central vision
- Retinal thickness
Clinical interest in this domain aligns with treatment goals for preserving and improving sight in patients with chronic retinal complications.
Multinational Clinical Development
Oculis Operations S.a.r.l. is conducting active studies across Europe, North America, and other international sites, supporting research in multicenter ophthalmology.
- Multicenter trials
- International site networks
- Recruiting ophthalmic studies
Its research footprint includes collaboration with numerous clinical sites, indicating sustained involvement in global development for retinal disorders.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Dexamethasone (OCS-01) Eye Drops in Diabetic Macular Edema: A Phase 3 Randomized, Double-Masked, Multicenter Study |  Bulgaria Czechia France Germany Italy Spain | Not Recruiting |
| Efficacy and Safety Evaluation of OCS-01 (Dexamethasone) Eye Drops in Diabetic Macular Edema: A Phase 2/3 Double-Masked, Randomized, Multicenter Study |  Hungary Spain | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 45 sites across their trial portfolio.
Therapeutic Focus
- 1.Ocular Physiological Phenomena2 trials6 other sponsors
Partnered Research Centres
45 centres- Address
- Floor 2, Ulitsa Perushtitsa 13b, 4002 Plovdiv
- Address
- Ostrovskeho 253/3, Smichov, 150 00 Prague
- Address
- Largo Giovanni Alessandro Brambilla 3, 50134 Florence
- Address
- Vaci Ut 76, Kerulet, 1133 Budapest
- Address
- Podmaniczky Utca 109, 1062 Budapest
- Address
- 40 Avenue De Verdun, 94000 Créteil
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Oculis Operations S.a.r.l..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.